Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: A pleiotropic effect of statins or a beneficial effect of hypercholesterolemia?

BMC Neurology

Volumn 10, Issue , 2010, Pages

  Arboix, Adrià ^a,b   García Eroles, Luis ^c   Oliveres, Montserrat ^a   Targa, Cecília ^a   Balcells, Miquel ^a   Massons, Joan ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Planning and Information Systems   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; BRAIN HEMATOMA; BRAIN ISCHEMIA; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FUNCTIONAL ASSESSMENT; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; INFECTION COMPLICATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PLEIOTROPY; RANKIN SCALE; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME; ANALYSIS OF VARIANCE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY; REGISTER; STATISTICAL MODEL; STROKE; TIME;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRAIN ISCHEMIA; FEMALE; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 77953640250     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-10-47     Document Type: Article

References (39)

1. Collins R, Armitage J, Parish S, Sleight P, Peto R. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular or other high-risk conditions. Lancet 2004, 363:757-767. 10.1016/S0140-6736(04)15690-0, 15016485.
2. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006, 355:549-559. 10.1056/NEJMoa061894, 16899775, The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators.
3. Blanco M, Nombela F, Castellanos M, Rodríguez-Yañez M, García-Gil M, Leira R, Lizasoain I, Serena J, Vivancos J, Moro MA, Dávalos A, Castillo J. Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology 2007, 28:904-910.
4. Brugts JJ, Yetgin T, Hoeks SE, Gotto AM, Shepherd J, Westendorp RG, de Craen AJ, Knopp RH, Nakamura H, Ridker P, van Domburg R, Deckers JW. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomized controlled trials. BMJ 2009, 338:b2376. 10.1136/bmj.b2376, 2714690, 19567909.
5. Salat D, Ribosa R, García-Bonilla L, Montaner J. Statin use before and after acute ischemic stroke onset improves neurological outcome. Expert Rev Cardiovasc Ther 2009, 7:1219-1230. 10.1586/erc.09.52, 19814665.
6. Tapia-Pérez H, S-anchez-Aguilar M, Torres-Corzo J, Rofdríguez-Leyva I, Herrera-González LB. Statins and brain protection mechanisms. Rev Neurol 2007, 45:359-364.
7. Nicholas JS, Swearingen CJ, Thomas JC, Rumboldt Z, Tumminello P, Patel SJ. The effect of statin pretreatment on infarct volume in ischemic stroke. Neuroepidemiology 2008, 31:48-56. 10.1159/000140095, 18560243.
8. Onder G, Volpato S, Liperoti R, D'Arco C, Maraldi C, Fellin R, Bernabei R, Landi F, . behalf of the GIFA Investigators Total serum cholesterol and recovery from disability among hospitalized older adults. J Gerontol Med Sci 2006, 61:736-741. behalf of the GIFA Investigators.
9. Vauthey C, de Freitas GR, van Melle G, Devuyst G, Bogousslavsky J. Better outcome after stroke with higher serum cholesterol levels. Neurology 2000, 54:1994-1948.
10. Arboix A, Cendrós V, Besa M, García-Eroles L, Oliveres M, Targa C, Balcells M, Comes E, Massons J. Trends in risk factors, stroke subtypes and outcome. Nineteen-year data from the Sagrat Cor Hospital of Barcelona Stroke Registry. Cerebrovasc Dis 2008, 26:509-516. 10.1159/000155989, 18810238.
11. Silver FL, Norris JW, Lewis AJ, Hachinski VC. Early mortality following stroke: a prospective review. Stroke 1984, 15:492-496.
12. Hosmer DW, Lemeshow S. Applied logistic regression 1989, London: John Wiley & Sons, Inc.
13. Martí-Fàbregas J, Gomis M, Arboix A, Aleu A, Pagonabarraga J, Belvís R, Cocho D, Roquer J, Rodríguez A, García MD, Molina-Porcel L, Díaz-Manera J, Martí-Vilalta JL. Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke 2004, 35:1117-1121. 10.1161/01.STR.0000125863.93921.3f, 15073403.
14. Montaner J, Chacon P, Krupinski J, Rubio F, Millán M, Molina CA, Hereu P, Quintana M, Alvarez-Sabín J. Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial. Eur J Neurol 2008, 15:82-90.
15. Paciaroni M, Bogousslvasky J. Statins and stroke prevention. Expert Rev Cardiovasc Ther 2009, 7:1231-1243. 10.1586/erc.09.106, 19814666.
16. Bang OY, Ovbiagele B, Liebeskind DS, Restrepo L, Yoon SR, Saver JL. Clinical determinants of infarct pattern subtypes in large vessel atherosclerotic stroke. J Neurol 2009, 256:591-599. 10.1007/s00415-009-0125-x, 2745818, 19444533.
17. Arboix A, Font A, Garro C, García-Eroles L, Comes E, Massons J. Recurrent lacunar infarction following a previous lacunar stroke: a clinical study of 122 patients. J Neurol Neurosurg Psychiatry 2007, 78:1392-1394. 10.1136/jnnp.2007.119776, 17615167.
18. Martínez-Sánchez P, Rivera-Ordóñez C, Fuentes B, Ortega-Casarrubios MA, Idrovo L, Díez-Tejedor E. The beneficial effect of statins treatment by stroke subtype. Eur J Neurol 2009, 16:127-133. 10.1111/j.1468-1331.2008.02370.x, 19049507.
19. Yoon S, Dambrosia J, Chalela J, Ezzeddine M, Warach S, Haymore J, Davis L, Baird AE. Rising statin use and effect on ischemic stroke outcome. BMC Medicine 2004, 2:4. 10.1186/1741-7015-2-4, 395844, 15035663.
20. Reeves MJ, Gargano JW, Luo Z, Mullard AJ, Jacobs BS, Majid A. Effect of pretreatment with statins on ischemic stroke outcomes. Stroke 2008, 39:1779-1785. 10.1161/STROKEAHA.107.501700, 18369173.
21. Ovbiagele B, Saver JL, Starkman S, Kim D, Ali LK, Jahan R, Duckwiler GR, Viñuela F, Pineda S, Liebeskind DS. Statin enhancement of collateralization in acute stroke. Neurology 2007, 68:2129-2131. 10.1212/01.wnl.0000264931.34941.f0, 17562834.
22. Zhang ZG, Chopp M. Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol 2009, 8:491-500. 10.1016/S1474-4422(09)70061-4, 2727708, 19375666.
23. Pretnar-Oblak J, Sabovic M, Sebestjen M, Pogacnik T, Zaletel M. The influence of atorvastatin treatment on L-arginine cerebrovascular reactivity and flow-mediated dilatation in patients with lacunar infarction. Stroke 2006, 37:2540-2545. 10.1161/01.STR.0000239659.99112.fb, 16931784.
24. Arboix A, Martí-Vilalta JL. Lacunar stroke. Expert Rev Neurother 2009, 9:179-196. 10.1586/14737175.9.2.179, 19210194.
25. Wardlaw JM. What causes lacunar stroke?. J Neurol Neurosurg Psychiatry 2005, 76:617-619. 10.1136/jnnp.2004.039982, 1739623, 15834013.
26. Son JW, Koh KK, Ahn JY, Jin DK, Park GS, Kim DS, Shin EK. Effects of statin on plaque stability and thrombogenicity in hypercholesterolemic patients with coronary artery disease. Int J Cardiol 2003, 88:77-82. 10.1016/S0167-5273(02)00368-6, 12659988.
27. Sironi L, Cimino M, Guerrini U, Calvio AM, Lodetti B, Asdente M, Balduini W, Paoletti R, Tremoli E. Treatment with statins alter induction of focal ischemia in rats reduces the extent of brain damage. Arterioscler Thromb Vasc Biol 2003, 23:322-327. 10.1161/01.ATV.0000044458.23905.3B, 12588778.
28. Moonis M, Kane K, Schwiderski U, Sandage BW, Fisher M. HMG-CoA reductase inhibitors improve acute ischemic stroke outcome. Stroke 2005, 36:1298-1300. 10.1161/01.STR.0000165920.67784.58, 15879346.
29. Chopp M, Li Y. Treatment of stroke and intracerebral hemorrhage with cellular and pharmacological restorative therapies. Acta Neurochir Suppl 2008, 105:79-83. full_text, 19066087.
30. Amarenco P, Bogousslavsky J, Callahan A, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KM, Zivin JA. Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006, 355:549-559. 10.1056/NEJMoa061894, 16899775.
31. Eryürek FG, Surmen E, Oner P, Altug T, Oz H. Gamma-glutamyl transpeptidase and acetylcholinesterase activities in brain capillaries of cholesterol-fed rabbits. Res Commun Chem Pathol Pharmacol 1990, 69:245-248.
32. Vatassery GT, Smith WE, Quach HT, Lai CK. In vitro oxidation of vitamin E, vitamin C, thiols, and cholesterol in rat brain mitochondria incubated with free radicals. Neurochem Int 1995, 26:527-535. 10.1016/0197-0186(94)00147-M, 7492950.
33. Girod WG, Jones SP, Sieber N, Aw TY, Lefer DJ. Effects of hypercholesterolemia on myocardial ischemia-reperfusion injury in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 1999, 19:2776-2781.
34. Lars Bastiaanse EM, Van der Valk-Kokshoorn LJM, Egas-Kenniphaas JM, Atsama DE, Van der Laarse A. The effect of sarcolemmal content on the tolerance to anoxia in cardiomyocite cultures. J Mol Cell Cardiol 1994, 26:639-648. 10.1006/jmcc.1994.1076, 8072018.
35. Dyker AG, Weir CJ, Lees KR. Influence of cholesterol on survival after stroke: retrospective study. BMJ 1997, 314:1584-1588. 2126812, 9169402.
36. Zuliani G, Cherubini A, Atti AR, Blè A, Vavalle C, Todaro FD, Benedetti C, Volpato S, Marinescu MG, Senin U, Fellin R. Low cholesterol levels are associated with short-term mortality in older patients with ischemic stroke. J Gerontol Med Sci 2004, 59:293-297.
37. Dávalos A, Ricart W, González-Huix F, Soler S, Marrugat J, Molins A. Effect of malnutrition after acute stroke on clinical outcome. Stroke 1996, 27:1028-1032.
38. Alvarez-Sabín J, Huertas R, Quintana M, Rubiera M, Delgado P, Ribó M, Molina CA, Montaner J. Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator. Stroke 2007, 38:1076-1078. 10.1161/01.STR.0000258075.58283.8f, 17272777.
39. Liu XS, Zhang ZG, Zhang L, Morris DC, Kapke A, Lu M, Chopp M. Atorvastatin downregulates tissue plasminogen activator-aggravated genes mediating coagulation and vascular permeability in single cerebral endothelial cells captured by laser microdissection. J Cereb Blood Flow Metab 2006, 26:787-796. 10.1038/sj.jcbfm.9600227, 16177809.